Prelude Capital Management, LLC 9 Meters Biopharma, Inc. Transaction History
Prelude Capital Management, LLC
- $1.39 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding NMTR
# of Institutions
4Shares Held
73.4KCall Options Held
0Put Options Held
0-
Ashfield Capital Partners, LLC33.4KShares$6670.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO30KShares$6000.0% of portfolio
-
Strategic Investment Solutions, Inc. /Il Orland Park, IL5.5KShares$1100.0% of portfolio
-
Wipfli Financial Advisors Llc,4.5KShares$900.0% of portfolio
About 9 METERS BIOPHARMA, INC.
- Ticker NMTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,955,400
- Market Cap $259K
- Description
- 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...